Preclinical animal studies in ischemic stroke: Challenges and some solutions

Area of Science:

• Neuroscience
• Translational Medicine
• Pharmacology

Background:

• Numerous neuroprotective drugs show promise in preclinical studies but fail in human clinical trials for ischemic stroke.
• A significant reason for this translational gap is the lack of robust animal models that accurately mimic human ischemic stroke.

Purpose of the Study:

• To review existing animal models of cerebral ischemia.
• To compare the Circle of Willis anatomy across species used in stroke research.
• To describe functional assessment tests employed in these models and explore discrepancies with human ischemic stroke.

Main Methods:

• Recapitulation of available cerebral ischemia animal models.
• Anatomical comparison of the Circle of Willis in different species.
• Description of functional assessment tests used in stroke models.

Main Results:

• Identified distinct differences between human ischemic stroke and experimental stroke models.
• Highlighted the limitations of current animal models in replicating human stroke pathology and outcomes.

Conclusions:

• Innovative animal models that more closely resemble human strokes are needed.
• Improved functional outcome assessment techniques and experimental designs are essential for generating stronger evidence.
• These advancements may facilitate the development of effective neuroprotective drugs for human ischemic stroke patients.